Join
Live feed
·
INSIDERFilingvia Quantisnow
NGM Biopharmaceuticals Inc. logo

Goeddel David V bought $18,332 worth of shares (26,811 units at $0.68), increasing direct ownership by 3% to 134,180 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
NGM· NGM Biopharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NGM (NGM Biopharmaceuticals Inc.) and more on Quantisnow.